Article
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
Journal of medicinal chemistry - 26 Nov 2009
Dexheimer Thomas S, Gediya Lalji K, Stephen Andrew G, Weidlich Iwona, Antony Smitha, Marchand Christophe, Interthal Heidrun, Nicklaus Marc, Fisher Robert J, Njar Vincent C, Pommier Yves
Abstract excerpt
Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is an enzyme that catalyzes the hydrolysis of 3'-phosphotyrosyl bonds. Such linkages form in vivo when topoisomerase I (Top1) processes DNA. For this reason, Tdp1 has been implicated in the repair of irreversible Top1-DNA covalent complexes. Tdp1 inhibitors have been regarded as potential therapeutics in combination with Top1 inhibitors, such as the camptothecin derivatives,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
